BioNTech SE (BNTX) Cash & Current Investments (2018 - 2025)

BioNTech SE has disclosed Cash & Current Investments across 8 years of filings, most recently posting $17.3 billion for Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $17.3 billion, down 3.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.3 billion (down 3.44% YoY), and the FY2025 annual result was $16.8 billion, down 6.28% from the prior year.
• Cash & Current Investments came in at $17.3 billion for Q4 2025 at BioNTech SE, up from $17.2 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1459786.9 billion in Q1 2021 to a low of $1.4 billion in Q3 2021.
• The 5-year median for Cash & Current Investments is $16.2 billion (2023), against an average of $73001.8 billion.
• Across the five-year window, Cash & Current Investments tumbled 100.0% in 2022 and surged 690.51% in 2023, its largest moves.
• BioNTech SE's Cash & Current Investments stood at $2.4 billion in 2021, then jumped by 504.7% to $14.3 billion in 2022, then climbed by 24.09% to $17.8 billion in 2023, then rose by 0.73% to $17.9 billion in 2024, then slipped by 3.44% to $17.3 billion in 2025.
• The last three Cash & Current Investments figures came in at $17.3 billion (Q4 2025), $17.2 billion (Q3 2025), and $15.8 billion (Q2 2025), per Business Quant data.